drugset / Trial / NCT01479556

Pregabalin for the Treatment and Prevention of Spinal Cord Injury Neuropathic Pain

NCT01479556

Phase 4 Unknown 82 enrolled Julian Taylor Green
RandomizedCrossoverTriple-blindTreatment

Summary

This study is a phase IV clinical trial with the objective of evaluating whether pain relief associated with pregabalin for at-level non-evoked and evoked neuropathic pain is more efficient during the early rather than late subacute phase of spinal cord injury.

Timeline

Start
2011-12
Primary completion
2014-05
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pregabalin Small molecule 150 mg Oral